Vincent Hansen

2.8k total citations
18 papers, 359 citations indexed

About

Vincent Hansen is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Vincent Hansen has authored 18 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Vincent Hansen's work include Nausea and vomiting management (6 papers), Anesthesia and Pain Management (5 papers) and Cancer Treatment and Pharmacology (4 papers). Vincent Hansen is often cited by papers focused on Nausea and vomiting management (6 papers), Anesthesia and Pain Management (5 papers) and Cancer Treatment and Pharmacology (4 papers). Vincent Hansen collaborates with scholars based in United States, Germany and Belgium. Vincent Hansen's co-authors include James P. Kushner, Samuel P. Hammar, Diane Provencher, Beth Y. Karlan, Prafull Ghatage, Setsuko K. Chambers, Charles H. Pippitt, Gary Richardson, Charles A. Leath and John V. Brown and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Vincent Hansen

18 papers receiving 349 citations

Peers

Vincent Hansen

MB

ONCOL

RM

SURGE

PFM

Konrad Stawiski Poland

Marcia A. Ciccone United States

Jean-François Rodier France

Richardson Rl United States

Anna V. Hoekstra United States

Koon‐Yat Wan Hong Kong

Emilia Pecori Italy

C Peters-Engl Austria

Heung Yeol Kim South Korea

Yi Kyeong Chun South Korea

Konrad Stawiski Poland

Vincent Hansen

235 ×2.0

MB

91 ×0.8

ONCOL

41 ×0.4

RM

87 ×0.9

SURGE

29 ×0.5

PFM

Citations per year, relative to Vincent Hansen Vincent Hansen (= 1×) peers Konrad Stawiski

Countries citing papers authored by Vincent Hansen

Since Specialization

Citations

This map shows the geographic impact of Vincent Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Hansen more than expected).

Fields of papers citing papers by Vincent Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Hansen. The network helps show where Vincent Hansen may publish in the future.

Co-authorship network of co-authors of Vincent Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Hansen. A scholar is included among the top collaborators of Vincent Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Hansen. Vincent Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Schwartzberg, Lee S., Meinolf Karthaus, Giorgia Rossi, et al.. (2019). Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double‐blind phase III studies. Cancer Medicine. 8(5). 2064–2073. 9 indexed citations

2.

Hansen, Vincent, et al.. (2018). An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Previously Treated Myeloma. Clinical Lymphoma Myeloma & Leukemia. 18(6). 400–407.e1. 6 indexed citations

3.

Hurvitz, Sara A., Arlene Chan, Nicholas Iannotti, et al.. (2018). Abstract P3-14-01: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2+ early-stage breast cancer: The CONTROL trial. Cancer Research. 78(4_Supplement). P3–14. 11 indexed citations

4.

Huddart, Robert, Ann Henry, John Staffurth, et al.. (2018). OC-0058: Clinical outcomes of the first rct of adaptive radiotherapy in bladder cancer (HYBRID CRUK/12/055). Radiotherapy and Oncology. 127. S25–S26. 3 indexed citations

5.

Ibrahim, Emad, Debu Tripathy, Mary Wilkinson, et al.. (2017). Abstract CT128: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients (pts) with HER2+ early-stage breast cancer (eBC): the CONTROL trial. Cancer Research. 77(13_Supplement). CT128–CT128. 15 indexed citations

6.

Aapro, Matti, Meinolf Karthaus, Lee S. Schwartzberg, et al.. (2016). NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron. Supportive Care in Cancer. 25(4). 1127–1135. 31 indexed citations

7.

Hansen, Vincent, et al.. (2015). An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Previously Treated Myeloma. Blood. 126(23). 3027–3027. 1 indexed citations

8.

Hansen, Vincent, et al.. (2013). Personality traits as a potential predictor of willingness to undergo various orthodontic treatments. The Angle Orthodontist. 83(5). 899–905. 15 indexed citations

9.

Karlan, Beth Y., Amit M. Oza, Gary Richardson, et al.. (2011). Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer. Journal of Clinical Oncology. 30(4). 362–371. 171 indexed citations

10.

Moesinger, Robert C., William Johnston, Carl Gray, et al.. (2011). Treatment of Pancreatic and Periampullary Cancers at a Community Hospital: Successful Application of Tertiary Care Treatment Standards. International Journal of Surgical Oncology. 2011. 1–8. 2 indexed citations

11.

Arpornwirat, Wichit, István Albert, Vincent Hansen, et al.. (2009). Phase 2 trial results with the novel neurokinin‐1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy‐induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy. Cancer. 115(24). 5807–5816. 21 indexed citations

12.

Herrstedt, Jørn, Wichit Arpornwirat, István Albert, et al.. (2008). Safety and efficacy of the novel antiemetic neurokinin-1 (NK-1) receptor antagonist, casopitant, in women with breast cancer (BC) receiving moderately emetogenic chemotherapy (MEC) – subgroup analysis from a randomized, double-blind, placebo-controlled phase II trial. European Journal of Cancer Supplements. 6(7). 196–197. 2 indexed citations

13.

Hansen, Vincent, Nashat Gabrail, Jeremey Levin, Rajesh Bandekar, & Jørn Herrstedt. (2008). Antiemetic efficacy of the novel neurokinin-1 (NK-1) antagonist, casopitant, in patients with GI cancers receiving oxaliplatin-based chemotherapy (OX): subgroup analysis from a randomized double-blind, placebo-controlled phase II trial. University of Southern Denmark Research Portal (University of Southern Denmark). 3 indexed citations

14.

Arpornwirat, Wichit, István Albert, Vincent Hansen, et al.. (2006). Multicenter, randomized, double-blind, ondansetron (ond)-controlled, dose-ranging, parallel group trial of the neurokinin-1 receptor antagonist (NK-1 RA) casopitant mesylate for chemotherapy-induced nausea/vomiting (CINV) in patients (pts) receiving moderately emetogenic chemotherapy (MEC). Journal of Clinical Oncology. 24(18_suppl). 8512–8512. 12 indexed citations

15.

Mitchell, Edith P., et al.. (2004). Cetuximab plus FOLFOX for colorectal cancer (EXPLORE): Preliminary safety analysis of a randomized phase III trial. Journal of Clinical Oncology. 22(14_suppl). 3531–3531. 8 indexed citations

16.

Mitchell, Edith P., et al.. (2004). Cetuximab plus FOLFOX for colorectal cancer (EXPLORE): Preliminary safety analysis of a randomized phase III trial. Journal of Clinical Oncology. 22(14_suppl). 3531–3531. 4 indexed citations

17.

Cotton, Frédéric, Henri Wajcman, Vincent Hansen, et al.. (2000). HB Anderlecht [α20(BL)HIS→PRO]: A Silent Variant Found in a Congolese Newborn. Hemoglobin. 24(4). 299–304. 5 indexed citations

18.

Kushner, James P., Vincent Hansen, & Samuel P. Hammar. (1975). Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin. Cancer. 36(5). 1577–1584. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact